Real-world data analysis of efficacy and survival after Lu-177 PSMA
177Lu-PSMA radioligand therapy provides a significant response rate with a [...]
PSMA Lu-177 x Ac-225
Available since 2015, the treatment of patients with metastatic castration-resistant [...]
Oncidium foundation welcomes it’s Turkish Ambassador
Welcome Mr. Hasan Ulaş Özcan as an Oncidium foundation Ambassador [...]